06.04.2013 Views

toxicological profile for malathion - Agency for Toxic Substances and ...

toxicological profile for malathion - Agency for Toxic Substances and ...

toxicological profile for malathion - Agency for Toxic Substances and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

MALATHION 105<br />

3. HEALTH EFFECTS<br />

<strong>for</strong> acute toxicity has not been determined. The overriding factor that makes the mammalian<br />

toxicokinetics of <strong>malathion</strong> unique is the rapid hydrolytic cleavage of carboxylic ester linkages that<br />

counters the buildup of the neurotoxic metabolite malaoxon. The impact of carboxylesterase on acute<br />

toxicity is evident in the rat in which the oral LD50 of <strong>malathion</strong> may be as low as 7.5 mg/kg when<br />

carboxylesterase is artificially suppressed (Dauterman <strong>and</strong> Main 1966; Main <strong>and</strong> Braid 1962) <strong>and</strong> as high<br />

as 10,000 mg/kg when carboxylesterase is fully active in the absence of interfering impurities. A similar,<br />

though less dramatic, effect of carboxylesterase inhibition has also been observed <strong>for</strong> malaoxon toxicity<br />

(Dauterman <strong>and</strong> Main 1966).<br />

Malathion also undergoes various other <strong>for</strong>ms of biotrans<strong>for</strong>mation. Both <strong>malathion</strong> <strong>and</strong> malaoxon are<br />

subject to phosphate linkage hydrolysis as well as glutathione-linked cleavage, both of which are<br />

detoxicative. Carboxylesterase is quite active in rat blood, but not in human blood (Main <strong>and</strong> Braid<br />

1962). In contrast, in both species, the enzyme is highly active in the liver. Since the blood enzyme in<br />

the rat apparently plays a major role in keeping the toxicity of this insecticide low, whether rats serve as a<br />

correct toxicokinetic model <strong>for</strong> humans is uncertain, particularly in view of the observed inter-specific<br />

variations. The efficient carboxylesterase hydrolysis masks various other pathways of biotrans<strong>for</strong>mation,<br />

<strong>and</strong> makes studies of toxicokinetics difficult. Further confounding the toxicokinetics is the varying<br />

amounts of impurities in commercial <strong>for</strong>mulations, which inhibit carboxylesterase to varying degrees<br />

depending on the <strong>for</strong>mulation. As a result, toxicokinetics depends not only on variations in the recipient<br />

sensitivity, but also on the purity of the <strong>malathion</strong> preparation at h<strong>and</strong>.<br />

3.4.1 Absorption<br />

Absorption of <strong>malathion</strong> has been studied either indirectly by following the urinary output of metabolites<br />

or directly by studies of disappearance of <strong>malathion</strong> from the site of application, typically by using<br />

<strong>malathion</strong> radiolabeled with 14 C at various parts of the molecule, including the methoxy, succinyl, <strong>and</strong><br />

ethyl groups. Though many of these studies also provide in<strong>for</strong>mation regarding elimination, studies<br />

concerning elimination as evidence of absorption are presented in this section, while other studies more<br />

directly addressing elimination are reviewed in Section 3.4.4, Elimination <strong>and</strong> Excretion.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!